X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6885) 6885
Book Chapter (16) 16
Conference Proceeding (6) 6
Magazine Article (2) 2
Book / eBook (1) 1
Dissertation (1) 1
Newsletter (1) 1
Newspaper Article (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6105) 6105
camptothecin - analogs & derivatives (6019) 6019
science & technology (5053) 5053
camptothecin - administration & dosage (5020) 5020
life sciences & biomedicine (4788) 4788
female (3777) 3777
male (3637) 3637
oncology (3444) 3444
antineoplastic combined chemotherapy protocols - therapeutic use (3299) 3299
middle aged (3054) 3054
aged (2882) 2882
adult (2354) 2354
irinotecan (1993) 1993
fluorouracil - administration & dosage (1797) 1797
colorectal neoplasms - drug therapy (1790) 1790
treatment outcome (1640) 1640
camptothecin - adverse effects (1471) 1471
chemotherapy (1451) 1451
animals (1442) 1442
camptothecin - therapeutic use (1342) 1342
cancer (1334) 1334
antineoplastic combined chemotherapy protocols - adverse effects (1276) 1276
leucovorin - administration & dosage (1231) 1231
colorectal neoplasms - pathology (1195) 1195
pharmacology & pharmacy (1162) 1162
organoplatinum compounds - administration & dosage (1149) 1149
colorectal cancer (1117) 1117
antineoplastic agents, phytogenic - administration & dosage (1084) 1084
antineoplastic combined chemotherapy protocols - administration & dosage (1069) 1069
drug administration schedule (1063) 1063
mice (896) 896
camptothecin - pharmacokinetics (879) 879
camptothecin - pharmacology (855) 855
cisplatin - administration & dosage (794) 794
disease-free survival (749) 749
aged, 80 and over (739) 739
antineoplastic agents - administration & dosage (710) 710
survival rate (692) 692
lung neoplasms - drug therapy (691) 691
adenocarcinoma - drug therapy (675) 675
cell line, tumor (661) 661
dose-response relationship, drug (651) 651
care and treatment (649) 649
liver neoplasms - secondary (643) 643
camptothecin (642) 642
neoplasm staging (633) 633
deoxycytidine - analogs & derivatives (619) 619
medicine & public health (600) 600
neoplasm metastasis (599) 599
bevacizumab (586) 586
metastasis (585) 585
neoplasms - drug therapy (533) 533
retrospective studies (532) 532
liver neoplasms - drug therapy (530) 530
antineoplastic agents, phytogenic - therapeutic use (522) 522
research (522) 522
deoxycytidine - administration & dosage (521) 521
antineoplastic agents - therapeutic use (519) 519
survival analysis (510) 510
antineoplastic agents (485) 485
infusions, intravenous (483) 483
antibodies, monoclonal - administration & dosage (477) 477
fluorouracil - adverse effects (465) 465
analysis (460) 460
prognosis (459) 459
antibodies, monoclonal, humanized (458) 458
fluorouracil - therapeutic use (453) 453
antimitotic agents (448) 448
camptothecin - chemistry (443) 443
colorectal neoplasms - mortality (442) 442
combined modality therapy (432) 432
antineoplastic agents, phytogenic - pharmacokinetics (425) 425
cetuximab (423) 423
antineoplastic agents, phytogenic - adverse effects (409) 409
drug therapy (409) 409
stomach neoplasms - drug therapy (406) 406
drug delivery systems (375) 375
mice, nude (369) 369
disease progression (358) 358
cancer research (355) 355
surgery (353) 353
tumors (353) 353
pharmacology/toxicology (352) 352
colorectal neoplasms - genetics (351) 351
oxaliplatin (351) 351
physical sciences (344) 344
capecitabine (343) 343
colonic neoplasms - drug therapy (328) 328
diarrhea - chemically induced (327) 327
follow-up studies (327) 327
drug combinations (326) 326
topoisomerase i inhibitors (325) 325
antineoplastic agents, phytogenic - pharmacology (322) 322
clinical trials (322) 322
maximum tolerated dose (321) 321
chemistry (320) 320
leucovorin - adverse effects (320) 320
tegafur - administration & dosage (320) 320
time factors (318) 318
antineoplastic agents - pharmacology (314) 314
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6351) 6351
Japanese (634) 634
Chinese (86) 86
French (49) 49
German (39) 39
Italian (25) 25
Hungarian (12) 12
Russian (12) 12
Spanish (8) 8
Korean (3) 3
Lithuanian (3) 3
Czech (2) 2
Danish (1) 1
Norwegian (1) 1
Polish (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The lancet oncology, ISSN 1470-2045, 05/2015, Volume 16, Issue 5, pp. 499 - 508
Journal Article
The Lancet (British edition), ISSN 0140-6736, 07/2016, Volume 388, Issue 10039, pp. 73 - 85
Summary Pancreatic cancer is a highly lethal disease, for which mortality closely parallels incidence. Most patients with pancreatic cancer remain asymptomatic... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Leucovorin - administration & dosage | Endosonography | Pancreatic Neoplasms - diagnosis | Proto-Oncogene Proteins p21(ras) - genetics | Humans | Tumor Suppressor Protein p53 - genetics | Carcinoembryonic Antigen - metabolism | Carcinoma, Pancreatic Ductal - genetics | Neoplasms, Cystic, Mucinous, and Serous - genetics | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Smad4 Protein - genetics | Carcinoma, Pancreatic Ductal - diagnosis | Camptothecin - administration & dosage | Paclitaxel - administration & dosage | Endoscopic Ultrasound-Guided Fine Needle Aspiration | Camptothecin - analogs & derivatives | Deoxycytidine - administration & dosage | Pancreatectomy | Albumins - administration & dosage | Pancreatic Neoplasms - genetics | Carcinoma, Pancreatic Ductal - therapy | Genes, p16 | CA-19-9 Antigen - metabolism | Neoplasms, Cystic, Mucinous, and Serous - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms, Cystic, Mucinous, and Serous - diagnosis | Deoxycytidine - analogs & derivatives | Pancreatic Neoplasms - therapy | Medical colleges | Ultrasound imaging | Oncology, Experimental | Mortality | Japan | Pancreatitis | Adjuvant treatment | Leucovorin | Research | Pancreatic cancer | Diagnosis | Tumor proteins | Health aspects | Cancer | Pathology | Chemotherapy | Medical prognosis | Metastasis | Health risk assessment | Cancer therapies | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 10/2015, Volume 16, Issue 13, pp. 1306 - 1315
Summary Background In the TRIBE study, FOLFOXIRI (fluorouracil, leucovorin, oxaliplatin, and irinotecan) plus bevacizumab significantly improved... 
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Leucovorin - administration & dosage | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Bevacizumab - therapeutic use | Bevacizumab - adverse effects | Colorectal Neoplasms - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Angiogenesis Inhibitors - administration & dosage | Neoplasm Metastasis | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Time Factors | DNA Mutational Analysis | Colorectal Neoplasms - drug therapy | Angiogenesis Inhibitors - therapeutic use | Camptothecin - administration & dosage | Female | Angiogenesis Inhibitors - adverse effects | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Bevacizumab - administration & dosage | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Proto-Oncogene Proteins - genetics | Treatment Outcome | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Intention to Treat Analysis | Italy | Aged | Infusions, Intravenous | Mutation | Colorectal Neoplasms - pathology | Antimitotic agents | Cancer patients | Care and treatment | Patient outcomes | Analysis | Colorectal cancer | Leucovorin | Metastasis | Antineoplastic agents | Index Medicus
Journal Article
Clinical cancer research, ISSN 1557-3265, 11/2017, Volume 23, Issue 21, pp. 6441 - 6449
Purpose: Anti-GD2 mAbs, acting via antibody-dependent cell-mediated cytotoxicity, may enhance the effects of chemotherapy. This pilot trial investigated a... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Drug-Related Side Effects and Adverse Reactions - blood | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Neuroblastoma - blood | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Neoplasm Recurrence, Local - drug therapy | Infant | Male | Drug-Related Side Effects and Adverse Reactions - pathology | Neoplasm Recurrence, Local - pathology | Antibodies, Monoclonal, Humanized - administration & dosage | Antibodies, Monoclonal, Humanized - pharmacokinetics | Dacarbazine - analogs & derivatives | Killer Cells, Natural - immunology | Camptothecin - administration & dosage | Female | Child | Neoplasm Recurrence, Local - blood | Neuroblastoma - pathology | Camptothecin - analogs & derivatives | Antibodies, Monoclonal, Humanized - adverse effects | Dacarbazine - administration & dosage | Gangliosides - antagonists & inhibitors | Interleukin-2 Receptor alpha Subunit - blood | Carboplatin - administration & dosage | Etoposide - administration & dosage | Treatment Outcome | Combined Modality Therapy | Cell- and Tissue-Based Therapy | Gangliosides - immunology | Disease-Free Survival | Ifosfamide - administration & dosage | Neuroblastoma - drug therapy | Adolescent | Topotecan - administration & dosage | Drug-Related Side Effects and Adverse Reactions - classification | Interleukin-2 - blood | Toxicity | Cytotoxicity | Malignancy | Neuroblastoma | Cerebrospinal fluid | Pain | Interleukin 2 | Surgery | Myelosuppression | Children | Natural killer cells | Antibody-dependent cell-mediated cytotoxicity | Thrombocytopenia | Immune response | Cytokines | Ifosfamide | Granulocyte-macrophage colony-stimulating factor | Hypersensitivity | Etoposide | Pharmacology | Patients | Irinotecan | Cyclophosphamide | Chemotherapy | Experimental design | Monoclonal antibodies | Carboplatin | Temozolomide | Pharmacokinetics | Cancer | Index Medicus
Journal Article
Cancer research (Chicago, Ill.), ISSN 1538-7445, 12/2011, Volume 72, Issue 3, pp. 779 - 789
The protein kinase BRAF is a key component of the RAS-RAF signaling pathway which plays an important role in regulating cell proliferation, differentiation,... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Erlotinib Hydrochloride | Area Under Curve | Capecitabine | Colorectal Neoplasms - genetics | Humans | Indoles - administration & dosage | Bevacizumab | Dose-Response Relationship, Drug | Antibodies, Monoclonal, Humanized - administration & dosage | Fluorouracil - administration & dosage | Colorectal Neoplasms - drug therapy | Camptothecin - administration & dosage | Indoles - pharmacology | Quinazolines - administration & dosage | Phosphorylation - drug effects | Cetuximab | Proto-Oncogene Proteins B-raf - metabolism | Camptothecin - analogs & derivatives | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | HCT116 Cells | Kaplan-Meier Estimate | Sulfonamides - pharmacology | Blotting, Western | Sulfonamides - pharmacokinetics | HT29 Cells | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Xenograft Model Antitumor Assays | Animals | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mice, Nude | Proto-Oncogene Proteins B-raf - genetics | Cell Line, Tumor | Indoles - pharmacokinetics | Cell Proliferation - drug effects | Mice | Mutation | Colorectal Neoplasms - pathology | Deoxycytidine - analogs & derivatives | Sulfonamides - administration & dosage | Drug Resistance, Neoplasm - drug effects | Mitogen-Activated Protein Kinases - metabolism | Index Medicus
Journal Article
British journal of cancer, ISSN 1532-1827, 06/2017, Volume 117, Issue 1, pp. 33 - 40
Background: Pembrolizumab (P) is an anti-PD-1 antibody that blocks the interaction between programmed cell death protein 1 (PD-1) on T-cells and PD-L1 and... 
clinical trial | pembrolizumab | advanced/metastatic solid tumours | phase I | chemotherapy | immunotherapy | Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - drug therapy | Nausea - chemically induced | Humans | Middle Aged | Male | Fatigue - chemically induced | Vinblastine - administration & dosage | Diarrhea - chemically induced | Small Cell Lung Carcinoma - drug therapy | Pancreatic Neoplasms - drug therapy | Antibodies, Monoclonal, Humanized - administration & dosage | Vinblastine - analogs & derivatives | Doxorubicin - analogs & derivatives | Adult | Camptothecin - administration & dosage | Female | Paclitaxel - administration & dosage | Ovarian Neoplasms - drug therapy | Camptothecin - analogs & derivatives | Doxorubicin - administration & dosage | Drug Eruptions - etiology | Deoxycytidine - administration & dosage | Albumins - administration & dosage | Treatment Outcome | Sarcoma - drug therapy | Adenocarcinoma - drug therapy | Breast Neoplasms - drug therapy | Polyethylene Glycols - administration & dosage | Neoplasms - drug therapy | Taxoids - administration & dosage | Vomiting - chemically induced | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Deoxycytidine - analogs & derivatives | Index Medicus | metastatic solid tumours | advanced | Clinical Study
Journal Article
The lancet oncology, ISSN 1470-2045, 05/2016, Volume 17, Issue 5, pp. 651 - 662
Journal Article
Annals of oncology, ISSN 0923-7534, 11/2009, Volume 20, Issue 11, pp. 1842 - 1847
Journal Article
The lancet oncology, ISSN 1470-2045, 10/2016, Volume 17, Issue 10, pp. 1426 - 1434
Journal Article